Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416025 · ClinicalTrials.gov registry record · Phase 4
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT01416025: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT01416025 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01416025, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, randomized trial to study therapeutic drug monitoring (TDM) of voriconazole among patients with an invasive mould infection (IMI). The primary objective of this study will be to assess the effect of prospective voriconazole TDM on the composite of adverse events (AE) and clinical response.
Interventions
- DRUG Prospective TDM Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416025
The ClinicalTrials.gov registry entry for NCT01416025 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prospective TDM Arm is the first listed.
NCT01416025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416025 about?
NCT01416025 is a clinical study titled "A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing". This is a prospective, multicenter, randomized trial to study therapeutic drug monitoring (TDM) of voriconazole among patients with an invasive mould infection (IMI). The primary objective of this study will be to assess the effect of prospective voriconazole TDM on the composite of adverse events (...
What is the current status of trial NCT01416025?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2012-01. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01416025?
The interventions under investigation include: Prospective TDM Arm (DRUG).
Who is sponsoring clinical trial NCT01416025?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.